◀ Back to RELA
CD86 — RELA
Text-mined interactions from Literome
Suzuki et al., Immunology 2003
:
These inhibitors interfered with
CD86 gene transcription in the
presence of activated
NF-kappaB , whereas phosphorylated CREB was down-regulated in the reactions where these inhibitors were added to inhibit CD86 gene expression
Podojil et al., J Biol Chem 2004
:
We showed that
CD86 stimulation
increased the nuclear localization of
NF-kappaB1 ( p50 ) and phosphorylated RelA ( p65 ) and increased Oct-2 expression and binding to the 3'-IgH enhancer, in a protein kinase C-dependent manner
Zou et al., J Cell Physiol 2005
:
We conclude that
NF-kappaB signal
plays a key role in LIGHT mediated upregulation of
CD86 expression
Jatana et al., Journal of neuroinflammation 2006
:
Furthermore, in vitro,
BW-B 70C inhibited lipopolysaccharide (LPS) mediated nitric oxide production, iNOS induction and
NF-kappaB activation in the BV2 microglial cell line
Yang et al., Biol Pharm Bull 2008
:
Activation of
NF-kappaB and ERK1/2 were
necessary for CD80,
CD86 and MHCII expression induced by semi-vioxanthin
Larangé et al., J Leukoc Biol 2009
:
We found that upon TLR7 and TLR8 activation, JNK and
NF-kappaB positively
regulated the expression of CCR7,
CD86 , CD83, and CD40 and the production of IL-6 and IL-12p40
Yin et al., Zhonghua Zhong Liu Za Zhi 2008
(Liver Neoplasms, Experimental) :
H22-CD80/CD86/CD137L ( + )
induces higher
NF-kappaB activity of the host T cells by synergistic action of CD28 and CD137, which may be one of the mechanisms of enhancement of the host CTL activity induced by co-expression of CD80, CD86 and CD137L genes